This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Feb 1;181(2):287-288.

doi: 10.1001/jamainternmed.2020.5044.

The Colchicine Debacle Revisited

B Joseph Guglielmo¹

Affiliations

PMID: 33252611
DOI: 10.1001/jamainternmed.2020.5044

Comment

The Colchicine Debacle Revisited

B Joseph Guglielmo. JAMA Intern Med. 2021.

. 2021 Feb 1;181(2):287-288.

doi: 10.1001/jamainternmed.2020.5044.

Author

B Joseph Guglielmo¹

Affiliation

¹ School of Pharmacy, University of California, San Francisco.

PMID: 33252611
DOI: 10.1001/jamainternmed.2020.5044

No abstract available

PubMed Disclaimer

Comment on

Prolonged Increases in Public-Payer Spending and Prices After Unapproved Drug Initiative Approval of Colchicine.
McCormick N, Wallace ZS, Yokose C, Jorge A, Sacks CA, Hsu J, Choi HK. McCormick N, et al. JAMA Intern Med. 2021 Feb 1;181(2):284-287. doi: 10.1001/jamainternmed.2020.5017. JAMA Intern Med. 2021. PMID: 33252616 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations